These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38502494)

  • 21. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 22. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.
    Dillon M; Flander L; Buchanan DD; Macrae FA; Emery JD; Winship IM; Boussioutas A; Giles GG; Hopper JL; Jenkins MA; Ait Ouakrim D
    PLoS Med; 2018 Aug; 15(8):e1002630. PubMed ID: 30114221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods.
    Borkhoff CM; Saskin R; Rabeneck L; Baxter NN; Liu Y; Tinmouth J; Paszat LF
    Can J Public Health; 2013 Jun; 104(4):e284-90. PubMed ID: 24044467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Area-level income disparities in colorectal screening in Canada: evidence to inform future surveillance.
    Blair A; Gauvin L; Ouédraogo S; Datta GD
    Curr Oncol; 2019 Apr; 26(2):e128-e137. PubMed ID: 31043818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
    Patel VB; Nahar R; Murray B; Salner AL
    Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
    Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
    PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada.
    Vahabi M; Lofters A; Wong JP; Ellison L; Graves E; Damba C; Glazier RH
    Cancer Med; 2019 Nov; 8(16):7108-7122. PubMed ID: 31568705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys.
    Kelly DM; Estaquio C; Léon C; Arwidson P; Nabi H
    BMJ Open; 2017 Dec; 7(12):e016941. PubMed ID: 29247085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer screening for average-risk North Americans: an economic evaluation.
    Heitman SJ; Hilsden RJ; Au F; Dowden S; Manns BJ
    PLoS Med; 2010 Nov; 7(11):e1000370. PubMed ID: 21124887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social inequalities in a population based colorectal cancer screening programme in the Basque Country.
    Hurtado JL; Bacigalupe A; Calvo M; Esnaola S; Mendizabal N; Portillo I; Idigoras I; Millán E; Arana-Arri E
    BMC Public Health; 2015 Oct; 15():1021. PubMed ID: 26438240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
    Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
    World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Approach to Analyze Disparities in Colorectal Cancer Screening and Mortality.
    Honaker MD; Burch AE; Wong JH; Akram WM; Irish WD
    J Surg Res; 2024 Jun; 298():347-354. PubMed ID: 38663261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer screening inequities in a time of primary care reform: a population-based longitudinal study in Ontario, Canada.
    Lofters AK; Mark A; Taljaard M; Green ME; Glazier RH; Dahrouge S
    BMC Fam Pract; 2018 Aug; 19(1):147. PubMed ID: 30157772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.
    Ladabaum U; Mannalithara A; Meester RGS; Gupta S; Schoen RE
    Gastroenterology; 2019 Jul; 157(1):137-148. PubMed ID: 30930021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
    van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
    Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing uptake of colorectal cancer screening in Korea: a population-based study.
    Choi KS; Jun JK; Lee HY; Hahm MI; Oh JH; Park EC
    BMC Public Health; 2010 May; 10():265. PubMed ID: 20492654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.